Major study to start for COVID-19 vaccine developed by Johnson & Johnson, Beth Israel
A coronavirus vaccine developed by Johnson & Johnson and Beth Israel Deaconess Medical Center will start undergoing testing on volunteers in a large study Wednesday, the fourth vaccine candidate to reach that milestone but the first that would offer protection from COVID-19 after one shot instead of two.

Read the full story.
Live tracker: Coronavirus vaccines to keep an eye on

We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list.
Like us
Follow us
You received this message because you signed up for Breaking News Alerts.

Copyright © 2020 The Boston Globe, All rights reserved.

Our mailing address is:
The Boston Globe
1 Exchange Place Suite 201
Boston, MA 02109-2132

Add us to your address book


unsubscribe from this list

Manage Your Account | Terms of Service | Privacy Policy | Help Center | Advertise